Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:58:42.890Z.
Consensus retrieved: 2026-10-06T16:28:56.057Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:58:42.890Z.
Quote observation: 2026-10-06T18:55:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2bec67efbd0228cb592a38c81264982f90af8fba553e645744a3942f8f5ba41c
FORWARD PE RATIO
N/A
Summit Therapeutics Inc.
Market Cap
$13.75B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Summit Therapeutics Inc. (SMMT) | $13.75B | N/A |
| Ascendis Pharma A/S (ASND)vs › | $14.19B | N/A |
| BridgeBio Pharma, Inc. (BBIO)vs › | $13.18B | N/A |
| Halozyme Therapeutics, Inc. (HALO)vs › | $13.11B | 13.13 |
| Neurocrine Biosciences, Inc. (NBIX)vs › | $14.53B | 20.46 |
| Corcept Therapeutics Incorporated (CORT)vs › | $12.86B | N/A |
| Tempus AI, Inc. (TEM)vs › | $12.84B | N/A |
| Jazz Pharmaceuticals plc (JAZZ)vs › | $14.60B | 9.31 |
| Exelixis, Inc. (EXEL)vs › | $14.67B | 16.61 |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.75B | 26.98 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in USD, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
